Free Trial

Tristel (LON:TSTL) Shares Pass Below 200 Day Moving Average - What's Next?

Tristel logo with Medical background

Tristel plc (LON:TSTL - Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 440.27 ($5.71) and traded as low as GBX 420 ($5.45). Tristel shares last traded at GBX 420 ($5.45), with a volume of 21,774 shares traded.

Tristel Price Performance

The company has a current ratio of 4.92, a quick ratio of 3.83 and a debt-to-equity ratio of 19.12. The company has a fifty day moving average price of GBX 409.63 and a two-hundred day moving average price of GBX 440.27. The firm has a market cap of £200.13 million, a P/E ratio of 3,230.77 and a beta of 0.23.

Tristel Increases Dividend

The business also recently declared a dividend, which will be paid on Friday, December 20th. Shareholders of record on Thursday, November 28th will be paid a GBX 8.28 ($0.11) dividend. The ex-dividend date is Thursday, November 28th. This represents a yield of 2.1%. This is a positive change from Tristel's previous dividend of $5.24. Tristel's payout ratio is presently 10,000.00%.

Insider Activity

In related news, insider Elizabeth Dixon sold 50,000 shares of the firm's stock in a transaction on Thursday, September 19th. The shares were sold at an average price of GBX 397 ($5.15), for a total transaction of £198,500 ($257,424.46). Corporate insiders own 4.89% of the company's stock.

About Tristel

(Get Free Report)

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.

Recommended Stories

→ Sell NVDA Now? (From Chaikin Analytics) (Ad)

Should you invest $1,000 in Tristel right now?

Before you consider Tristel, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tristel wasn't on the list.

While Tristel currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Energy Vault’s 100% Stock Jump: CEO Discusses $350M Project in Australia in MarketBeat CEO Series
Market Shifts After Election: What Stocks Could Benefit Most?
Post-Election Chaos or Opportunity? Prepare Your Investments

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines